Venus Remedies gets Responsible Export Organisation Certification from CII

New Delhi: Venus Remedies Ltd has received the prestigious Responsible Export Organisation (REO) Certification from the Confederation of lndian Industry (Cll) following an elaborate screening and assessment process.

A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess.

"Being the first pharmaceutical manufacturer to receive this certification, Venus Remedies is poised to set industry standards which enhance the competitiveness of Indian exports while focusing on expansion in new and existing markets," the company said in its recent release.

Saransh Chaudhary, president, global critical care, Venus Remedies, and CEO, Venus Medicine Research Centre, said, "The REO certification from the CII will provide further impetus to our export business and give us an edge in global markets. Exports account for 70 per cent of our revenue, and this certification will enable us to go from strength to strength to emerge as an export powerhouse."

Read also: Venus Remedies forays into consumer healthcare division, introduces pain management solution R3SET

Venus Remedies has global footprint in more than 80 countries across five continents, including regulated and other markets like the UK, ltaly, Australia, Germany, France, Kazakhstan, South Africa, Mexico, lsrael, Hong Kong, Saudi Arabia, Philippines, Thailand, Oman.

VRL has 11 overseas marketing offices, more than 750 market authorisations, and more than 450 pending authorisations in regulated and emerging markets apart from strategic alliances with leading multinationals. The company has more than 25 international GMP certifications from the European Union, WHO, Latin America, Australia, Saudi Arabia, Australia, Latin America, Ukraine, Zimbabwe, Uganda, Syria, Columbia, Kenya, Yemen, Indonesia and lran, among others. Venus has more than 100 patent for its innovative research products worldwide.

Recently awarded the WHO Good Distribution Practices (GDP) certification, Venus Remedies is also a recipient of the Authorised Economic Operator certification from the Directorate of International Customs, Central Board of Indirect Taxes & Customs.

Read also: Venus Remedies joins AMR Industry Alliance